Natural Biogenex Private Limited (Material Subsidiary) at its BM held on May 27, 2026, has approved right issue of 11,11,200 equity shares of Rs. 10/-
NATCAPSUQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Natural Biogenex Private Limited, the material subsidiary of Natural Capsules Ltd, has approved a rights issue of 11,11,200 equity shares of ₹10 each at par value. The issue aggregates to ₹1,11,12,000 (approximately ₹1.11 crore). The shares are being offered for cash at face value. The parent company Natural Capsules Ltd is listed on BSE (scrip code: 524654) and NSE (symbol: NATCAPSUQ). The filing was made under SEBI (LODR) Regulations, 2015.
This rights issue by the unlisted material subsidiary will raise capital for the subsidiary, which could strengthen its financials. Since the issue is at par value, existing shareholders of the subsidiary may face dilution. The impact on Natural Capsules Ltd stock is likely minimal unless the subsidiary's operations are material to the parent company's consolidated financials.